Radioresistance in Glioblastoma and the Development of Radiosensitizers
Related Experiment Video
Updated: Dec 9, 2025
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
Published on: March 6, 2012
Md Yousuf Ali1,2,3, Claudia R Oliva2,3, Abu Shadat M Noman4,5
1Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA 52242, USA.
Abstract:
Ionizing radiation is a common and effective therapeutic option for the treatment of glioblastoma (GBM). Unfortunately, some GBMs are relatively radioresistant and patients have worse outcomes after radiation treatment. The mechanisms underlying intrinsic radioresistance in GBM has been rigorously investigated over the past several years, but the complex interaction of the cellular molecules and signaling pathways involved in radioresistance remains incompletely defined. A clinically effective radiosensitizer that overcomes radioresistance has yet to be identified. In this review, we discuss the current status of radiation treatment in GBM, including advances in imaging techniques that have facilitated more accurate diagnosis, and the identified mechanisms of GBM radioresistance. In addition, we provide a summary of the candidate GBM radiosensitizers being investigated, including an update of subjects enrolled in clinical trials. Overall, this review highlights the importance of understanding the mechanisms of GBM radioresistance to facilitate the development of effective radiosensitizers.
Insights
Glioblastoma (GBM) often resists radiation therapy, leading to poor patient outcomes. Understanding GBM radioresistance mechanisms is crucial for developing effective radiosensitizers to improve treatment efficacy.
Area of Science:
- Neuro-oncology
- Radiation oncology
- Molecular biology
Background:
- Ionizing radiation is a standard glioblastoma (GBM) treatment.
- Intrinsic radioresistance in some GBMs leads to suboptimal patient outcomes.
- Mechanisms of GBM radioresistance are complex and not fully understood.
Purpose of the Study:
- To review the current status of radiation therapy for GBM.
- To discuss identified mechanisms of GBM radioresistance.
- To summarize candidate radiosensitizers and their clinical trial progress.
Main Methods:
- Literature review of radiation treatment in GBM.
- Analysis of advances in diagnostic imaging for GBM.
- Compilation of research on GBM radioresistance mechanisms.
- Summary of ongoing clinical trials for GBM radiosensitizers.
Main Results:
- Radiation therapy is a common GBM treatment, but radioresistance is a significant challenge.
- Advances in imaging improve GBM diagnosis and treatment planning.
- Several molecular mechanisms contribute to GBM radioresistance.
- Various radiosensitizers are under investigation, with some in clinical trials.
Conclusions:
- Understanding GBM radioresistance is key to developing effective radiosensitizers.
- Further research into molecular pathways is needed.
- Clinical trials are essential for validating new radiosensitizing agents.
